Honliv Healthcare Management Group Company Limited
HKEX:9906.HK
1.51 (HKD) • At close July 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 768.725 | 760.527 | 727.789 | 606.837 | 524.043 | 531.108 | 496.551 | 478.924 |
| Cost of Revenue
| 642.033 | 615.683 | 589.394 | 471.531 | 386.451 | 360.952 | 336.585 | 319.294 |
| Gross Profit
| 126.692 | 144.844 | 138.395 | 135.306 | 137.592 | 170.156 | 159.966 | 159.63 |
| Gross Profit Ratio
| 0.165 | 0.19 | 0.19 | 0.223 | 0.263 | 0.32 | 0.322 | 0.333 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 76.384 | 71.953 | 73.345 | 68.545 | 71.199 | 21.286 | 6.716 | 6.687 |
| Selling & Marketing Expenses
| 0 | 15.734 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 76.384 | 87.687 | 73.345 | 68.545 | 71.199 | 21.286 | 6.716 | 6.687 |
| Other Expenses
| -0.113 | -0.288 | -0.421 | -0.556 | -0.244 | 52.596 | 0.178 | 0.157 |
| Operating Expenses
| 76.271 | 87.399 | 72.924 | 67.989 | 70.955 | 73.882 | 48.923 | 45.908 |
| Operating Income
| 50.421 | 57.445 | 61.561 | 66.561 | 61.97 | 96.481 | 111.649 | 113.862 |
| Operating Income Ratio
| 0.066 | 0.076 | 0.085 | 0.11 | 0.118 | 0.182 | 0.225 | 0.238 |
| Total Other Income Expenses Net
| -7.723 | -6.023 | 1.46 | -16.019 | -31.117 | -28.002 | -13.177 | -17.919 |
| Income Before Tax
| 42.698 | 51.422 | 63.021 | 50.542 | 30.853 | 68.479 | 98.472 | 95.943 |
| Income Before Tax Ratio
| 0.056 | 0.068 | 0.087 | 0.083 | 0.059 | 0.129 | 0.198 | 0.2 |
| Income Tax Expense
| 11.222 | 12.724 | 13.678 | 13.524 | 8.662 | 18.621 | 25.008 | 24.224 |
| Net Income
| 31.151 | 38.31 | 48.947 | 36.615 | 21.84 | 49.362 | 72.727 | 71.001 |
| Net Income Ratio
| 0.041 | 0.05 | 0.067 | 0.06 | 0.042 | 0.093 | 0.146 | 0.148 |
| EPS
| 0.062 | 0.066 | 0.08 | 0.06 | 0.04 | 0.082 | 0.12 | 0.12 |
| EPS Diluted
| 0.062 | 0.066 | 0.08 | 0.06 | 0.04 | 0.082 | 0.12 | 0.12 |
| EBITDA
| 125.801 | 119.306 | 127.128 | 98.198 | 79.434 | 116.2 | 135.774 | 140.083 |
| EBITDA Ratio
| 0.164 | 0.157 | 0.175 | 0.162 | 0.152 | 0.219 | 0.273 | 0.292 |